The Journal of clinical investigation
An in vivo screening platform identifies senolytic compounds that target p16INK4a+ fibroblasts in lung fibrosis.
Nuclear IL-33 as a growth and survival agent within basal cells.
Integrin α2β1 regulates collagen I tethering to modulate hyperresponsiveness in reactive airway disease models.
Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury.
Lung megakaryocytes are immune modulatory cells.
Corticosteroids, COVID-19 pneumonia and acute respiratory distress syndrome.
The ABO Histo-Blood Group, endothelial activation, and acute respiratory distress syndrome risk in critical illness.
Complement activation on endothelium initiates antibody-mediated acute lung injury.
Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier.
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.
